Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Biotech
Hidden data on obesity prospect wipe $12B off Amgen market cap
The hidden Excel tab contains data on bone density changes in patients who received Amgen’s obesity prospect MariTide in a phase 1 trial.
Nick Paul Taylor
Nov 13, 2024 6:35am
Amgen disappears lung disease program after phase 2 fail
Oct 30, 2024 5:59pm
Less than a year in, BenevolentAI CEO is out—Chutes & Ladders
Oct 18, 2024 8:30am
Amgen reports first phase 3 win for $400M eczema drug
Sep 25, 2024 5:50am
Generate gains another $1B-plus Big Pharma partner in Novartis
Sep 24, 2024 6:00am
Amgen, Merck join academic clinical trial diversity partnership
Sep 16, 2024 3:10pm
